Lexicon Pharmaceuticals
LXRX
#6186
Rank
NZ$1.77 B
Marketcap
NZ$4.00
Share price
0.65%
Change (1 day)
99.58%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$99.71 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's total debt is NZ$99.71 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Lexicon Pharmaceuticals - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31NZ$0.10 B-43.57%
2024-12-31NZ$0.19 B14.6%
2023-12-31NZ$0.16 B92.58%
2022-12-31NZ$87.09 M2510.21%
2021-12-31NZ$3.33 M-81.21%
2020-12-31NZ$17.75 M-95.13%
2019-12-31NZ$0.36 B-0.1%
2018-12-31NZ$0.36 B5.59%
2017-12-31NZ$0.34 B136.19%
2016-12-31NZ$0.14 B-2.62%
2015-12-31NZ$0.15 B9.45%
2014-12-31NZ$0.13 B416.17%
2013-12-31NZ$26.62 M-6.61%
2012-12-31NZ$28.5 M-10.63%
2011-12-31NZ$31.89 M-13.61%
2010-12-31NZ$36.91 M-59.96%
2009-12-31NZ$92.19 M75.47%
2008-12-31NZ$52.54 M28.29%
2007-12-31NZ$40.95 M-10.36%
2006-12-31NZ$45.68 M-15.46%
2005-12-31NZ$54.04 M2.48%
2004-12-31NZ$52.73 M-39.16%
2003-12-31NZ$86.67 M1034.05%
2002-12-31NZ$7.64 M
2000-12-31NZ$6.42 M-29.76%
1999-12-31NZ$9.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
NZ$74.57 B 74,693.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$4.39 B 4,308.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$4.67 B 4,589.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
NZ$62.2 M-37.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.78 B 683.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.43 B 337.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$0.58 B 483.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.48 B 2,394.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$0.67 M-99.33%๐Ÿ‡บ๐Ÿ‡ธ USA